Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables RefundsShares IssuedShares RepurchasedShort-Term Debt issuancesWages, Salaries and Other
Ratios

Amphastar Pharmaceuticals (AMPH) Shares Repurchased (2016 - 2025)

Historic Shares Repurchased for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Q3 2025 value amounting to $4.8 million.

  • Amphastar Pharmaceuticals' Shares Repurchased fell 8612.62% to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $97.1 million, marking a year-over-year increase of 1408.56%. This contributed to the annual value of $85.5 million for FY2024, which is 4697.65% up from last year.
  • Per Amphastar Pharmaceuticals' latest filing, its Shares Repurchased stood at $4.8 million for Q3 2025, which was down 8612.62% from $39.2 million recorded in Q2 2025.
  • In the past 5 years, Amphastar Pharmaceuticals' Shares Repurchased registered a high of $50.0 million during Q3 2023, and its lowest value of $128000.0 during Q2 2023.
  • Over the past 5 years, Amphastar Pharmaceuticals' median Shares Repurchased value was $9.5 million (recorded in 2023), while the average stood at $16.2 million.
  • The largest annual percentage gain for Amphastar Pharmaceuticals' Shares Repurchased in the last 5 years was 55215.62% (2023), contrasted with its biggest fall of 9790.75% (2023).
  • Quarter analysis of 5 years shows Amphastar Pharmaceuticals' Shares Repurchased stood at $13.4 million in 2021, then surged by 34.48% to $18.1 million in 2022, then soared by 176.72% to $50.0 million in 2023, then dropped by 16.0% to $42.0 million in 2024, then tumbled by 88.45% to $4.8 million in 2025.
  • Its Shares Repurchased stands at $4.8 million for Q3 2025, versus $39.2 million for Q2 2025 and $11.0 million for Q1 2025.